Skip Content
Page Banner Image

2020 Postcard from Palm Springs

Highlights from the 2020 CHDI HD Therapeutics Conference are now here!


This year’s Postcard covers HTT-lowering therapeutics, including an update on the Roche ASO Phase 3 trial, brand new therapeutic approaches that have come out of the GWAS modifier gene studies, and a just-published study of premanifest HD in young adults.

We support those facing huntington disease
 Latest Blog


Let Us Know How We Can Help
Enter your name, email address and question(s) below for assistance.



Stay in Touch!
Enter your email address below to receive occasional updates.

Newsletter Sign-up